发育条件期间的轮暴露 帕金森症现象在年轻成年大鼠中的帕金森症现象
Margarita Gómez-Chavarín1, Patricia Padilla2, Mireya Velázquez-Paniagua1
1Physiology Department, Medicine School, National University of Mexico, Ciudad de México 04500, Mexico.
Toxics
|April 25, 2025
概括
在发育过程中暴露于环境农药rotenone可以在成年大鼠中引起帕金森病症状. 产前暴露显示出最显著的影响,影响运动技能和大脑神经化学.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 发展生物学 发展生物学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,与多巴胺基神经元损失和α-synuclein积累有关.
- 环境毒素越来越多地与PD的胎儿起源有关,破坏神经发育.
- 导致PD病因的特定发育阶段和病原体需要进一步调查.
研究的目的:
- 调查在关键发育期内暴露于轮 (ROT) 对老鼠帕金森病样病理学的长期影响.
- 确定围产期ROT暴露是否会使后代在成年时易患神经退行和运动缺陷.
主要方法:
- 雌性大鼠在怀孕,母乳养或两种期间都暴露于农药罗 (ROT).
- 成年后代的运动技能,α-syn蛋白 (α-syn) 水平,多巴胺能神经元数量和DNA甲基化都被评估.
- 研究人员检查了阴腹道的完整性和功能.
主要成果:
- 周产期ROT暴露诱导了成年大鼠黑体 (S. nigra) 中的多巴胺基神经元退化.
- 后代的运动技能下降,尾状核 (C.核) 和S. nigra中的α-syn增加,氨酸氧酶阳性神经元减少.
- 在暴露的老鼠中观察到全球5甲基氨酸DNA的低甲基化.
- 在子宫和子宫/哺乳期的联合暴露中,影响最严重.
结论:
- 早期暴露于环境毒素罗特的暴露可能会导致成年后的帕金森病类似症状.
- 发育阶段会影响敏感性,而产前暴露尤其有害.
- 这些发现凸显了PD病变发生过程中环境因素在发育过程中的关键作用.
相关概念视频
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310


